Align Expertise Inc introduced a positive judgment from the Jinan Intermediate Folks’s Courtroom in China relating to a patent infringement lawsuit in opposition to Angelalign Expertise’s working subsidiaries within the nation. In response, Angelalign said it should enchantment the August 10 ruling, noting the choice has not but taken impact.
Particulars of the Ruling
The lawsuit, filed by Align in September 2025, facilities on extraction-gap-closure expertise. The court docket discovered that Angel’s use of its masterForce biomechanical simulation system and ATreat digital orthodontic remedy design system to generate A7 and A7 Velocity premolar extraction remedy options infringes on Align’s patent rights.
In response to a launch from Align Expertise, the court docket ordered Angel to cease utilizing the patented expertise, stop manufacturing and promoting the infringing merchandise in China, and pay Align RMB 10 million in damages.
“We respect the function of China’s courts in defending mental property rights and are inspired by this choice,” says Joe Hogan, president and CEO of Align Expertise, in a launch. “Defending mental property is crucial to sustaining that innovation and making certain continued funding in applied sciences that profit medical doctors and sufferers.”
Angelalign to Enchantment
Angelalign maintains that its A7 Premolar Extraction Resolution doesn’t infringe on any legitimate patent. In a launch, Angelalign emphasised that the preliminary choice solely applies in China and has not impacted its clients or sufferers.
“The court docket’s choice is restricted to China. Even in China, there isn’t a speedy influence on our clients,” says Fox Hu, CEO of Angel, in a launch. “We really feel superb about progress in orthodontist assist for our skilled options all over the world. We really feel assured about successful this enchantment in opposition to our competitor, given we’ve gained a collection of comparable circumstances.”
Angelalign highlighted earlier authorized victories in opposition to Align, together with a Might 2026 ruling by the Native Division Düsseldorf of the Unified Patent Courtroom in Germany, which rejected Align’s request for an injunction in opposition to the A7 answer. In the identical launch, the corporate additionally referenced two June 2026 judgments from the Zhengzhou Intermediate Folks’s Courtroom in China that dismissed Align’s claims in separate patent disputes.
Ongoing International Litigation
The Jinan court docket ruling is a part of a broader, ongoing authorized battle between the 2 clear aligner producers.
Align famous a February 2026 preliminary injunction issued by the Unified Patent Courtroom requiring Angel to stop infringement of Align’s ClinCheck Stay Replace expertise, a choice upheld on enchantment. Moreover, the US Worldwide Commerce Fee held an evidentiary listening to in July 2026 regarding 5 patents asserted by Align in opposition to Angel. An preliminary willpower from the fee relating to the deserves of Align’s claims is anticipated in November 2026.
Photograph: ID 196112614 © Serhii Yevdokymov | Dreamstime.com
